Tamara R. McBrayer

1.7k total citations
47 papers, 1.3k citations indexed

About

Tamara R. McBrayer is a scholar working on Infectious Diseases, Hepatology and Molecular Biology. According to data from OpenAlex, Tamara R. McBrayer has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 26 papers in Hepatology and 21 papers in Molecular Biology. Recurrent topics in Tamara R. McBrayer's work include HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (25 papers) and Biochemical and Molecular Research (15 papers). Tamara R. McBrayer is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), Hepatitis C virus research (25 papers) and Biochemical and Molecular Research (15 papers). Tamara R. McBrayer collaborates with scholars based in United States, France and Belgium. Tamara R. McBrayer's co-authors include Raymond F. Schinazi, Lieven Stuyver, Michaël Otto, Tony Whitaker, Phillip M. Tharnish, Kyoichi A. Watanabe, Stefania Lostia, Junxing Shi, Phillip A. Furman and Steven J. Coats and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Tamara R. McBrayer

46 papers receiving 1.2k citations

Peers

Tamara R. McBrayer
Phillip M. Tharnish United States
Tony Whitaker United States
Sonal Rajyaguru United States
Jin-Hua Sun United States
Sophie Le Pogam United States
Anne B. Eldrup United States
Junxing Shi United States
Stefania Lostia United States
John H. Merrett United Kingdom
Marija Prhavc United States
Phillip M. Tharnish United States
Tamara R. McBrayer
Citations per year, relative to Tamara R. McBrayer Tamara R. McBrayer (= 1×) peers Phillip M. Tharnish

Countries citing papers authored by Tamara R. McBrayer

Since Specialization
Citations

This map shows the geographic impact of Tamara R. McBrayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara R. McBrayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara R. McBrayer more than expected).

Fields of papers citing papers by Tamara R. McBrayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara R. McBrayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara R. McBrayer. The network helps show where Tamara R. McBrayer may publish in the future.

Co-authorship network of co-authors of Tamara R. McBrayer

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara R. McBrayer. A scholar is included among the top collaborators of Tamara R. McBrayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara R. McBrayer. Tamara R. McBrayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amblard, Franck, Sijia Tao, Rana Abdelnabi, et al.. (2025). 1′-Cyanocytidine-5′-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamsters. Science Advances. 11(40). eadz5913–eadz5913.
2.
Patel, Dharmeshkumar, Sujin Lee, Shaoman Zhou, et al.. (2025). Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis. Antiviral Research. 241. 106245–106245. 1 indexed citations
3.
Hurwitz, Selwyn J., Keivan Zandi, Tamara R. McBrayer, et al.. (2024). Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections. Viruses. 16(4). 651–651. 3 indexed citations
4.
Amblard, Franck, Shaoman Zhou, Peng Liu, et al.. (2024). Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease. European Journal of Medicinal Chemistry. 268. 116263–116263. 5 indexed citations
5.
Zandi, Keivan, Vivian Vasconcelos Costa, Franck Amblard, et al.. (2022). Discovery of a 2′-Fluoro,2′-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice. Microorganisms. 10(11). 2098–2098. 3 indexed citations
6.
Tao, Sijia, Keivan Zandi, Leda Bassit, et al.. (2021). Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside. SHILAP Revista de lepidopterología. 2. 100045–100045. 19 indexed citations
7.
Roy, Vincent, Julien Marlet, Catherine Gaudy‐Graffin, et al.. (2021). Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs. Molecules. 26(5). 1493–1493. 7 indexed citations
8.
Chen, Zhe, Bryan D. Cox, Ethel C. Garnier‐Amblard, et al.. (2017). Synthesis and anti-HCV activity of a series of β-d-2′-deoxy-2′-dibromo nucleosides and their corresponding phosphoramidate prodrugs. Bioorganic & Medicinal Chemistry Letters. 27(23). 5296–5299. 11 indexed citations
9.
Li, Hao, Tamara R. McBrayer, Leda Bassit, et al.. (2016). Synthesis and antiviral evaluation of fluorinated acyclo-nucleosides and their phosphoramidates. Nucleosides Nucleotides & Nucleic Acids. 36(1). 66–82. 4 indexed citations
10.
Tao, Sijia, Franck Amblard, Richard A. Stanton, et al.. (2015). Design, synthesis and evaluation of novel anti-HCV molecules that deliver intracellularly three highly potent NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3711–3715. 2 indexed citations
11.
Zhou, Longhu, Franck Amblard, Hongwang Zhang, et al.. (2013). Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(11). 3385–3388. 7 indexed citations
12.
Pradère, Ugo, Peng Liu, Chengwei Li, et al.. (2013). Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6325–6330. 17 indexed citations
13.
Amblard, Franck, Hongwang Zhang, Longhu Zhou, et al.. (2013). Synthesis and evaluation of non-dimeric HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 2031–2034. 21 indexed citations
14.
Roy, Vincent, Tamara R. McBrayer, Tony Whitaker, et al.. (2013). Synthesis and broad spectrum antiviral evaluation of bis(POM) prodrugs of novel acyclic nucleosides. European Journal of Medicinal Chemistry. 67. 398–408. 21 indexed citations
15.
Martínez‐Montero, Saúl, Susana Fernández, Yogesh S. Sanghvi, et al.. (2012). Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2′,3′-dideoxy-2′,2′-difluoro-4′-azanucleosides. Bioorganic & Medicinal Chemistry. 20(23). 6885–6893. 25 indexed citations
16.
Shi, Junxing, Longhu Zhou, Franck Amblard, et al.. (2012). Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(10). 3488–3491. 19 indexed citations
17.
Shi, Junxing, Longhu Zhou, Hongwang Zhang, et al.. (2011). Synthesis and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5′-triphosphates. Bioorganic & Medicinal Chemistry Letters. 21(23). 7094–7098. 16 indexed citations
18.
Amblard, Franck, Emilie Fromentin, Mervi Detorio, et al.. (2009). Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases. European Journal of Medicinal Chemistry. 44(10). 3845–3851. 8 indexed citations
19.
Pradère, Ugo, Vincent Roy, Tamara R. McBrayer, Raymond F. Schinazi, & Luigi A. Agrofoglio. (2008). Preparation of ribavirin analogues by copper- and ruthenium-catalyzed azide-alkyne 1,3-dipolar cycloaddition. Tetrahedron. 64(38). 9044–9051. 66 indexed citations
20.
Shi, Junxing, Jinfa Du, Tianwei Ma, et al.. (2005). Synthesis and anti-viral activity of a series of d- and l-2′-deoxy-2′-fluororibonucleosides in the subgenomic HCV replicon system. Bioorganic & Medicinal Chemistry. 13(5). 1641–1652. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip M. Tharnish Breakdown of academic impact, for papers by Tony Whitaker Breakdown of academic impact, for papers by Sonal Rajyaguru Breakdown of academic impact, for papers by Jin-Hua Sun Breakdown of academic impact, for papers by Sophie Le Pogam Breakdown of academic impact, for papers by Anne B. Eldrup Breakdown of academic impact, for papers by Junxing Shi Breakdown of academic impact, for papers by Stefania Lostia Breakdown of academic impact, for papers by John H. Merrett Breakdown of academic impact, for papers by Marija Prhavc
Rankless by CCL
2026